Glucocorticoid Treatment of Symptomatic Sarcoidosis in 2 Morbidly Obese Patients
- PMID: 30766416
- PMCID: PMC6366578
Glucocorticoid Treatment of Symptomatic Sarcoidosis in 2 Morbidly Obese Patients
Abstract
Corticosteroid management for patients with sarcoidosis requires the need for close monitoring to detect and manage any complications that may arise during treatment.
Conflict of interest statement
Author disclosures The authors report no actual or potential conflicts of interest with regard to this article.
References
-
- Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med. 2007;357(21):2153–2165. - PubMed
-
- Valeyre D, Prasse A, Nunes H, Uzunhan Y, Brillet PY, Muller-Quernheim J. Sarcoidosis. Lancet. 2014;383(9923):1155–1167. - PubMed
-
- Lal C, Medarov BI, Judson MA. Interrelationship between sleep-disordered breathing and sarcoidosis. Chest. 2015;148(4):1105–1114. - PubMed
-
- Dobarro D, Schreiber BE, Handler C, Beynon H, Denton CP, Coghlan JG. Clinical characteristics, haemodynamics and treatment of pulmonary hypertension in sarcoidosis in a single centre, and meta-analysis of the published data. Am J Cardiol. 2013;111(2):278–285. - PubMed
LinkOut - more resources
Full Text Sources